Amgen AMGN announced its Q4 earnings on Tuesday, February 4, 2025 at 04:01 PM.
Here's a breakdown of the earnings report.
Earnings
Amgen beat estimated earnings by 5.0%, reporting an EPS of $5.31 versus an estimate of $5.08.
Revenue was up $890.00 million from the same period last year.
Past Earnings Performance
In the previous quarter, the company beat on EPS by $0.47, resulting in a 1.0% increase change in the share price the following day.
Here's a look at Amgen's past performance:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | 5.11 | 5 | 3.87 | 4.62 |
| EPS Actual | 5.58 | 4.97 | 3.96 | 4.71 |
| Revenue Estimate | 8.52B | 8.33B | 6.94B | 8.13B |
| Revenue Actual | 8.50B | 8.39B | 7.45B | 8.20B |
To track all earnings releases for Amgen visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
